Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amman Pharmaceutical Industries (API) is a prominent pharmaceutical manufacturer based in Jordan, specializing in the production of high-quality branded generic medications. Founded in 1989, the company has established itself as a leader in the Middle East and North Africa (MENA) region, particularly through its flagship Apisal brand of saline solutions. API's diverse product portfolio includes ophthalmic, nasal, otic, and topical preparations, as well as oral liquids and solids. The company maintains rigorous quality standards, with facilities certified by various international regulatory bodies, enabling export to over 30 global markets. API continues to expand its reach through strategic partnerships and a focus on niche therapeutic areas such as ophthalmology and dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apisal.